Bariatric procedures and microbiota: patient selection and outcome prediction.
bariatric endoscopy
bariatric surgery
gut microbiota
obesity
Journal
Therapeutic advances in gastrointestinal endoscopy
ISSN: 2631-7745
Titre abrégé: Ther Adv Gastrointest Endosc
Pays: United States
ID NLM: 101741179
Informations de publication
Date de publication:
Historique:
received:
10
01
2020
accepted:
11
04
2021
entrez:
9
8
2021
pubmed:
10
8
2021
medline:
10
8
2021
Statut:
epublish
Résumé
Obesity is a major health issue throughout the world and bariatric surgery plays a key role in its management and treatment. The role of microbiota in determining the pathogenesis of obesity has been widely studied, while its role in determining the outcome of bariatric surgery is an emerging issue that will be an outcome in near future studies. Studies on mice first showed the key role of microbiota in determining obesity, highlighting the fat mass increase in mice transplanted with microbiota from fat individuals, as well as the different microbiota composition between mice undergone to low-fat or high-fat diets. This led to characterize the asset of microbiota composition in obesity: increased abundance of Firmicutes, reduced abundance of Bacteroidetes and other taxonomical features. Variations on the composition of gut microbiome have been detected in patients undergone to diet and/or bariatric surgery procedures. Patients undergone to restricting diets showed lower level of trimethylamine
Identifiants
pubmed: 34368762
doi: 10.1177/26317745211014746
pii: 10.1177_26317745211014746
pmc: PMC8299956
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
26317745211014746Informations de copyright
© The Author(s), 2021.
Déclaration de conflit d'intérêts
Conflict of interest statement: The authors received no financial support for the research, authorship, and/or publication of this article.
Références
Science. 2013 Sep 6;341(6150):1069-70
pubmed: 24009379
Gut. 2016 Mar;65(3):426-36
pubmed: 26100928
Microb Ecol Health Dis. 2015 Feb 02;26:25877
pubmed: 25651995
Curr Opin Biotechnol. 2015 Apr;32:21-27
pubmed: 25448228
Am J Physiol Endocrinol Metab. 2019 Sep 1;317(3):E446-E459
pubmed: 31265324
Front Biosci (Elite Ed). 2018 Jun 1;10:495-505
pubmed: 29772522
Curr Opin Pediatr. 2015 Aug;27(4):496-501
pubmed: 26087428
Exp Ther Med. 2019 Mar;17(3):2268-2278
pubmed: 30867711
Gastroenterology. 2009 May;136(5):1476-83
pubmed: 19327360
J Nutr Biochem. 2019 Mar;65:54-65
pubmed: 30623851
Am J Transl Res. 2019 Feb 15;11(2):942-952
pubmed: 30899393
EPMA J. 2017 Oct 10;8(4):357-376
pubmed: 29209439
Obes Surg. 2017 Apr;27(4):917-925
pubmed: 27738970
Diabetes. 2010 Dec;59(12):3049-57
pubmed: 20876719
PLoS One. 2019 Sep 23;14(9):e0218143
pubmed: 31545802
Int J Obes (Lond). 2019 Dec;43(12):2509-2517
pubmed: 30765893
World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):110-9
pubmed: 26600968
Diabetes Care. 2019 Aug;42(8):1365-1371
pubmed: 31332027
Benef Microbes. 2018 Apr 25;9(3):367-373
pubmed: 29482339
Sci Rep. 2018 Oct 23;8(1):15625
pubmed: 30353027
Sci Rep. 2017 Jul 21;7(1):6109
pubmed: 28733671